Site notifications

Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1125 result(s) found, displaying 626 to 650

  • AusPAR: Gadobutrol

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Gadobutrol

  • AusPAR: Insulin glargine (rbe)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Insulin glargine (rbe)

  • AusPAR: Ivacaftor

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ivacaftor

  • AusPAR: Kaldyeco

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ivacaftor

  • AusPAR: Alirocumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tiotropium bromide

  • AusPAR: Buprenorphine

    Australian public assessment report (AusPar)
    AusPAR: Buprenorphine

  • AusPAR: Tiotropium bromide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tiotropium bromide

  • AusPAR: Secukinumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Secukinumab

  • AusPAR: Selexipag

    Australian public assessment report (AusPar)
    Australian Assessment Report for Selexipag

  • AusPAR: Avanafil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Avanafil

  • AusPAR: Idarucizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Idarucizumab

  • AusPAR: Dexamethasone

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for dexamethasone

  • AusPAR: Ulipristal acetate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ulipristal acetate

  • AusPAR: Pembrolizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pembrolizumab (rch)

  • AusPAR: Tocilizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tocilizumab (rch)

  • AusPAR: Lesinurad

    Australian public assessment report (AusPar)
    Australian public assessment report for Lesinurad

  • AusPAR: Lumacaftor / ivacaftor

    Australian public assessment report (AusPar)
    Australian public assessment report for Lumacaftor / ivacaftor

  • AusPAR: Lenvatinib mesilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Lenvatinib mesilate

  • AusPAR: Nivolumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nivolumab